Changes in the Concentration of Markers Participating in the Regulation of the Apoptosis Receptor Pathway Involving Soluble Tumour Necrosis Factor Ligand inducing Apoptosis (sTRAIL) and Osteoprotegerin (OPG) in the Serum of Women with Ovarian Cancer—Participation in Pathogenesis or a Possible Clinical Use?

Changes in the Concentration of Markers Participating in the Regulation of the Apoptosis Receptor Pathway Involving Soluble Tumour Necrosis Factor Ligand inducing Apoptosis (sTRAIL) and Osteoprotegerin (OPG) in the Serum of Women with Ovarian Cancer—Participation in Pathogenesis or a Possible Clinical Use?

Due to the ability to selectively induce apoptosis in cancer cells, the most interesting target for clinical research is the tumour necrosis factor ligand inducing apoptosis (TRAIL), which binds specific receptors, including osteoprotegerin (OPG). The aim of the study was to analyse the concentratio...

Full description

Bibliographic Details
Main Authors: Aleksandra Mielczarek-Palacz, Zdzisława Kondera-Anasz, Marta Smycz-Kubańska
Format: Article
Language:English
Published: MDPI AG 2020-03-01
Series:Cells
Subjects:
osteoprotegerin
trail
ovarian cancer
apoptosis
Online Access:https://www.mdpi.com/2073-4409/9/3/612

Internet

https://www.mdpi.com/2073-4409/9/3/612

Similar Items